BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21822824)

  • 1. Chronic inflammation and hepatocellular carcinoma.
    Alison MR; Nicholson LJ; Lin WR
    Recent Results Cancer Res; 2011; 185():135-48. PubMed ID: 21822824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and liver cancer: new molecular links .
    Berasain C; Castillo J; Perugorria MJ; Latasa MU; Prieto J; Avila MA
    Ann N Y Acad Sci; 2009 Feb; 1155():206-21. PubMed ID: 19250206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular study of the hepatic inflammation to fibrosis to cancer axis].
    Cai WM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):799-800. PubMed ID: 19874704
    [No Abstract]   [Full Text] [Related]  

  • 5. Kahweol Ameliorates the Liver Inflammation through the Inhibition of NF-κB and STAT3 Activation in Primary Kupffer Cells and Primary Hepatocytes.
    Seo HY; Kim MK; Lee SH; Hwang JS; Park KG; Jang BK
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29973533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role for inositol-requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet-induced obesity in mice.
    Wu Y; Shan B; Dai J; Xia Z; Cai J; Chen T; Lv S; Feng Y; Zheng L; Wang Y; Liu J; Fang J; Xie D; Rui L; Liu J; Liu Y
    Hepatology; 2018 Aug; 68(2):533-546. PubMed ID: 29506314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
    Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
    J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidermal growth factor receptor: a link between inflammation and liver cancer.
    Berasain C; Perugorria MJ; Latasa MU; Castillo J; Goñi S; Santamaría M; Prieto J; Avila MA
    Exp Biol Med (Maywood); 2009 Jul; 234(7):713-25. PubMed ID: 19429859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer: an inflammatory link.
    Balkwill F; Coussens LM
    Nature; 2004 Sep; 431(7007):405-6. PubMed ID: 15385993
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
    Elsharkawy AM; Mann DA
    Hepatology; 2007 Aug; 46(2):590-7. PubMed ID: 17661407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB and STAT3 - key players in liver inflammation and cancer.
    He G; Karin M
    Cell Res; 2011 Jan; 21(1):159-68. PubMed ID: 21187858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
    Jiang R; Tan Z; Deng L; Chen Y; Xia Y; Gao Y; Wang X; Sun B
    Hepatology; 2011 Sep; 54(3):900-9. PubMed ID: 21674558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase.
    Chuma M; Sakamoto N; Nakai A; Hige S; Nakanishi M; Natsuizaka M; Suda G; Sho T; Hatanaka K; Matsuno Y; Yokoo H; Kamiyama T; Taketomi A; Fujii G; Tashiro K; Hikiba Y; Fujimoto M; Asaka M; Maeda S
    Carcinogenesis; 2014 Feb; 35(2):272-81. PubMed ID: 24130164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.
    Pardo-Saganta A; Latasa MU; Castillo J; Alvarez-Asiain L; Perugorría MJ; Sarobe P; Rodriguez-Ortigosa CM; Prieto J; Berasain C; Santamaría M; Avila MA
    J Hepatol; 2009 Dec; 51(6):1010-20. PubMed ID: 19815304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
    Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
    J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma].
    Kwon OS; Choi SH; Kim JH
    Korean J Gastroenterol; 2015 Dec; 66(6):320-4. PubMed ID: 26691189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma.
    Lu X; Wo G; Li B; Xu C; Wu J; Jiang C; Wei J
    Biomed Pharmacother; 2018 Jun; 102():420-427. PubMed ID: 29574282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.